OFIX

SEC source: 0001209191-23-002670 · doc4.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,312

F1 · shares: The restricted stock units vest with respect to one-fourth (1/4th) of the shares of stock covered hereby on each of the first, second, third, and fourth anniversaries of the Grant Date.

SEC source: 0001209191-23-002660 · doc4.xml · nonDerivative · entry 3

Serbousek Jon Carl · CIK 0001536875 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 358,110

F3 · shares: Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025.

F4 · balance_after: Includes 307,621 unvested restricted stock units.

SEC source: 0001209191-23-002660 · doc4.xml · nonDerivative · entry 2

Serbousek Jon Carl · CIK 0001536875 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,143

F2 · shares: Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024.

SEC source: 0001209191-23-002660 · doc4.xml · nonDerivative · entry 1

Serbousek Jon Carl · CIK 0001536875 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,379

F1 · shares: Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023.

SEC source: 0001209191-23-002664 · doc4.xml · derivative · entry 5

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,566

Underlying: Common Stock · 84,566 shares

Expires 2033-01-05

F5 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0001209191-23-002664 · doc4.xml · nonDerivative · entry 4

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,179

F4 · shares: Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025.

SEC source: 0001209191-23-002664 · doc4.xml · nonDerivative · entry 3

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,687

F3 · shares: Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024.

SEC source: 0001209191-23-002664 · doc4.xml · nonDerivative · entry 2

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,458

F2 · shares: Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023.

SEC source: 0001209191-23-002664 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,924

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

SEC source: 0001209191-23-002662 · doc4.xml · nonDerivative · entry 3

Serbousek Jon Carl · CIK 0001536875 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 358,110

F3 · shares: Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025.

F4 · balance_after: Includes 307,621 unvested restricted stock units.

SEC source: 0001209191-23-002662 · doc4.xml · nonDerivative · entry 2

Serbousek Jon Carl · CIK 0001536875 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,143

F2 · shares: Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024.

SEC source: 0001209191-23-002662 · doc4.xml · nonDerivative · entry 1

Serbousek Jon Carl · CIK 0001536875 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,379

F1 · shares: Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023.

SEC source: 0001209191-23-002658 · doc4.xml · nonDerivative · entry 1

Hinrichs James F. · CIK 0001506974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,557

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023.

F2 · balance_after: Includes 39,246 deferred stock units.

SEC source: 0001209191-23-002654 · doc4.xml · nonDerivative · entry 1

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,460

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023.

F2 · balance_after: Includes 14,052 deferred stock units.

SEC source: 0001209191-23-002657 · doc4.xml · nonDerivative · entry 1

Maniar Shweta · CIK 0001850826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,040

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023.

F2 · balance_after: Includes 14,052 deferred stock units.

SEC source: 0001209191-23-002652 · doc4.xml · nonDerivative · entry 1

ESSIG STUART · CIK 0001187574 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,664

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023.

F2 · balance_after: Includes 14,052 deferred stock units.

SEC source: 0001209191-23-002650 · doc4.xml · nonDerivative · entry 1

Hannon Jason · CIK 0001330401 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,285

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023.

F2 · balance_after: Includes 29,336 deferred stock units.

SEC source: 0001209191-23-002649 · doc4.xml · derivative · entry 2

Keran Patrick L · CIK 0001372290 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,566

Underlying: Common Stock · 84,566 shares

Expires 2033-01-05

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0001209191-23-002649 · doc4.xml · nonDerivative · entry 1

Keran Patrick L · CIK 0001372290 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,198

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F2 · balance_after: Includes 60,212 unvested restricted stock units.

SEC source: 0001209191-23-002646 · doc4.xml · derivative · entry 2

Bostjancic John J. · CIK 0001644860 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,566

Underlying: Common Stock · 84,566 shares

Expires 2033-01-05

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0001209191-23-002646 · doc4.xml · nonDerivative · entry 1

Bostjancic John J. · CIK 0001644860 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,147

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F2 · balance_after: Includes 62,451 unvested restricted stock units.

SEC source: 0001209191-23-002645 · doc4.xml · nonDerivative · entry 1

BURZIK CATHERINE M · CIK 0001261141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,754

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023.

F2 · balance_after: Includes 28,872 deferred stock units.

SEC source: 0001209191-23-002642 · doc4.xml · derivative · entry 2

Valentine Keith · CIK 0001289408 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,264

Underlying: Common Stock · 338,264 shares

Expires 2033-01-05

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0001209191-23-002642 · doc4.xml · nonDerivative · entry 1

Valentine Keith · CIK 0001289408 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,855

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F2 · balance_after: Includes 260,896 unvested restricted stock units.

SEC source: 0001209191-23-002640 · doc4.xml · nonDerivative · entry 1

Paolucci Michael E · CIK 0001599463 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,687

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023.

F2 · balance_after: Includes 39,246 deferred stock units.

SEC source: 0001209191-23-004479 · doc4a.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,350

F1 · kind: Shares of Common Stock of Issuer acquired pursuant to the terms of the merger between the Issuer and SeaSpine Holdings Corporation ("SeaSpine") which became effective on January 5, 2023 (the "Merger"), in exchange for 2,000 shares of Common Stock of SeaSpine, shares having a market value of $22.76 per share at the effective time of the Merger.

F1 · shares: Shares of Common Stock of Issuer acquired pursuant to the terms of the merger between the Issuer and SeaSpine Holdings Corporation ("SeaSpine") which became effective on January 5, 2023 (the "Merger"), in exchange for 2,000 shares of Common Stock of SeaSpine, shares having a market value of $22.76 per share at the effective time of the Merger.

SEC source: 0001209191-23-008130 · doc4a.xml · nonDerivative · entry 1

Paolucci Michael E · CIK 0001599463 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,989

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.

F2 · shares: This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.

F3 · balance_after: Includes 39,548 deferred stock units.

SEC source: 0001209191-23-008138 · doc4a.xml · nonDerivative · entry 1

BURZIK CATHERINE M · CIK 0001261141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,056

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.

F2 · shares: This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.

F3 · balance_after: Includes 29,174 deferred stock units.

SEC source: 0001209191-23-008134 · doc4a.xml · nonDerivative · entry 1

Hinrichs James F. · CIK 0001506974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,859

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.

F2 · shares: This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.

F3 · balance_after: Includes 39,548 deferred stock units.

SEC source: 0001209191-23-008128 · doc4a.xml · nonDerivative · entry 1

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,762

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.

F2 · shares: This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.

F3 · balance_after: Includes 14,354 deferred stock units.

SEC source: 0001209191-23-008126 · doc4a.xml · nonDerivative · entry 1

ESSIG STUART · CIK 0001187574 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,966

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.

F2 · shares: This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.

F3 · balance_after: Includes 14,354 deferred stock units.

SEC source: 0001209191-23-008124 · doc4a.xml · nonDerivative · entry 1

Maniar Shweta · CIK 0001850826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,342

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.

F2 · shares: This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.

F3 · balance_after: Includes 14,354 deferred stock units.

SEC source: 0001209191-23-008122 · doc4a.xml · nonDerivative · entry 1

Hannon Jason · CIK 0001330401 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,587

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders.

F2 · shares: This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023.

F3 · balance_after: Includes 29,638 deferred stock units.

SEC source: 0001209191-23-002113 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,795

F1 · shares: Represents time-based vesting restricted stock units that vest in 1/3 increments on the first, second and third anniversaries of grant date, January 3, 2023.

F2 · balance_after: Includes 76,365 shares of unvested restricted stock units.

SEC source: 0001209191-22-059674 · doc4.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,407

SEC source: 0001209191-22-055521 · doc4.xml · nonDerivative · entry 1

Serbousek Jon Carl · CIK 0001536875 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,551

SEC source: 0001209191-23-003009 · doc5.xml · nonDerivative · entry 1

West Thomas A. · CIK 0001620705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,055

F1 · shares: Shares purchased pursuant to the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan, as Amended (the "Stock Purchase Plan") for the plan period ended October 31, 2022.

F2 · price: Pursuant to the terms of the Stock Purchase Plan, shares are purchased at 85% of the fair market value of the Orthofix stock on the first day of the plan period or, if lower, on the last day of the plan period. Accordingly, shares were purchased at $13.65 per share, or at 85% of the quoted market price of $16.06 on October 31, 2022.

SEC source: 0001209191-23-003004 · doc5.xml · nonDerivative · entry 1

MARKS LILLY · CIK 0001645735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,813

F1 · shares: Shares purchased pursuant to the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan, as Amended (the "Stock Purchase Plan") for the plan period ended October 31, 2022.

F2 · price: Pursuant to the terms of the Stock Purchase Plan, shares are purchased at 85% of the fair market value of the Orthofix stock on the first day of the plan period or, if lower, on the last day of the plan period. Accordingly, shares were purchased at $13.65 per share, or at 85% of the quoted market price of $16.06 on October 31, 2022.

SEC source: 0001209191-22-049010 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,085

SEC source: 0001209191-22-045058 · doc4.xml · nonDerivative · entry 1

Serbousek Jon Carl · CIK 0001536875 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,920

SEC source: 0001209191-22-035049 · doc4.xml · nonDerivative · entry 1

BURZIK CATHERINE M · CIK 0001261141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,443

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022.

SEC source: 0001209191-22-035048 · doc4.xml · nonDerivative · entry 1

BURRIS WAYNE · CIK 0001885420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,383

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022.

SEC source: 0001209191-22-035046 · doc4.xml · nonDerivative · entry 1

Hannon Jason · CIK 0001330401 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,501

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022.

SEC source: 0001209191-22-035044 · doc4.xml · nonDerivative · entry 1

Hinrichs James F. · CIK 0001506974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,727

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022.

SEC source: 0001209191-22-035043 · doc4.xml · nonDerivative · entry 1

West Thomas A. · CIK 0001620705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,543

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022.

SEC source: 0001209191-22-035038 · doc4.xml · nonDerivative · entry 1

Paolucci Michael E · CIK 0001599463 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,903

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022.

SEC source: 0001209191-22-035040 · doc4.xml · nonDerivative · entry 1

SICARD JOHN · CIK 0001734027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,615

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022.

SEC source: 0001209191-22-035037 · doc4.xml · nonDerivative · entry 1

MARKS LILLY · CIK 0001645735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,520

F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022.

SEC source: 0001209191-22-024289 · doc4.xml · nonDerivative · entry 1

Kenny Kevin J. · CIK 0001520400 · President of Global Spine

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,625

F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and forth anniversaries of the grant date, April 11, 2022.

SEC source: 0001209191-22-024288 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,450

F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and forth anniversaries of the grant date, April 11, 2022.